The Need to Advocate for Fair HIV Drug Prices
March 4, 2017
In an interview on behalf of IFARA at CROI 2017, Fred Schaich spoke with Lynda Dee and Tim Horn about the price of HIV medications and the work of the Fair Pricing Coalition. The organization was formed in response to the initial price of early antiretrovirals. It works to lower the price of drugs when they are first approved by the U.S. Food and Drug Administration, to keep price increases for medications at the consumer price index level and to advocate with governmental bodies for legislative measures on drug pricing.
The cost of almost all antiretrovirals still under patent increases by about 6%-9% per year, well above the rise in the consumer price index, said Tim Horn. He added that the highest expenditure in public health insurance programs, such as Medicaid and Medicare, is medication. The U.S. has a very complex health care delivery and pricing system compared with European systems. While federal policies are important in this respect, much of the health care infrastructure is handled on the state level.
Lynda Dee urged people to make their legislators aware of the effect that medication pricing has on them.
More information about the Fair Pricing Coalition is available at www.fairpricingcoalition.org.
Watch the video to learn more:
The video above has been posted on TheBodyPRO.com with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's website or YouTube channel to watch more video interviews from the conference, as well as earlier meetings.
Follow Barbara on Twitter: @reliabletran.
This article was provided by TheBodyPRO. It is a part of the publication The 24th Conference on Retroviruses and Opportunistic Infections.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.)
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.